{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:56:16Z","timestamp":1795046176454,"version":"4.10.2"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol Exp"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Identifying patients at risk of chemoresistant osteosarcoma enables risk-adapted management. This study aimed to predict chemoresistant osteosarcoma using baseline clinical and magnetic resonance (MRI)-derived radiomics features, with histological response as the reference standard and external validation included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This retrospective single-center study included 115 patients with osteosarcoma from an institutional registry as the internal cohort, divided into training and test sets, and 49 patients from another institution as an external validation cohort. Tumor and peritumoral regions were manually segmented on baseline fat-suppressed T2-weighted MRI. Radiomics features were extracted using PyRadiomics, followed by two feature selection methods to identify potential predictors. Six machine learning models with varying feature combinations were trained to classify histologic chemoresistance in the internal training set. Model performance was assessed in the internal test set, and the best model was externally validated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The support vector machine model combining eight tumor radiomics features and four clinical-imaging parameters (presence of tumor necrosis &gt; 50% on contrast-enhanced MRI, age, body mass index, and presence of metastasis at presentation) demonstrated the best performance. In the internal test set, it achieved a sensitivity of 83.3%, a specificity of 72.7%, an area under the receiver operating characteristic curve (AUROC) of 0.84, and a positive likelihood ratio of 3.06. External validation yielded a sensitivity of 88.5%, a specificity of 47.8%, and an AUROC of 0.77.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A model combining tumor radiomics and clinical parameters at diagnosis showed strong performance in predicting chemoresistant osteosarcoma, with results confirmed by external validation. This approach may support personalized treatment strategies in high-grade osteosarcoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Relevance statement<\/jats:title>\n                    <jats:p>The validated model may support early, individualized osteosarcoma management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Baseline T2-weighted MRI radiomics and clinical data can predict chemoresistant osteosarcoma.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Tumor radiomics combined with clinical features achieved strong predictive accuracy.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The support vector machine model reached an AUROC of 0.84 for the internal testing and of 0.77 for the external validation.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The validated model may support early, individualized osteosarcoma management.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s41747-026-00732-z","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:53:28Z","timestamp":1779288808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predicting resistance to neoadjuvant chemotherapy in osteosarcoma using machine learning with clinical data and T2-weighted MRI radiomics"],"prefix":"10.1186","volume":"10","author":[{"given":"Papangkorn","family":"Inkeaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dumnoensun","family":"Pruksakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salita","family":"Angkurawaranon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wipawee","family":"Morakote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pattira","family":"Boonsri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rattanathon","family":"Phettom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1980-1903","authenticated-orcid":false,"given":"Thanat","family":"Kanthawang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"732_CR1","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00432-010-0923-7","volume":"137","author":"MU Jawad","year":"2011","unstructured":"Jawad MU, Cheung MC, Clarke J, Koniaris LG, Scully SP (2011) Osteosarcoma: improvement in survival limited to high-grade patients only. J Cancer Res Clin Oncol 137:597\u2013607. https:\/\/doi.org\/10.1007\/s00432-010-0923-7","journal-title":"J Cancer Res Clin Oncol"},{"key":"732_CR2","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/cncr.24121","volume":"115","author":"L Mirabello","year":"2009","unstructured":"Mirabello L, Troisi RJ, Savage SA (2009) Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer 115:1531\u20131543. https:\/\/doi.org\/10.1002\/cncr.24121","journal-title":"Cancer"},{"key":"732_CR3","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1200\/jco.2002.20.3.776","volume":"20","author":"SS Bielack","year":"2002","unstructured":"Bielack SS, Kempf-Bielack B, Delling G et al (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20:776\u2013790. https:\/\/doi.org\/10.1200\/jco.2002.20.3.776","journal-title":"J Clin Oncol"},{"key":"732_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1177\/1043454206289786","volume":"23","author":"E Hendershot","year":"2006","unstructured":"Hendershot E, Pappo A, Malkin D, Sung L (2006) Tumor necrosis in pediatric osteosarcoma: impact of modern therapies. J Pediatr Oncol Nurs 23:176\u2013181. https:\/\/doi.org\/10.1177\/1043454206289786","journal-title":"J Pediatr Oncol Nurs"},{"key":"732_CR5","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s00256-016-2410-y","volume":"45","author":"T Kubo","year":"2016","unstructured":"Kubo T, Furuta T, Johan MP, Adachi N, Ochi M (2016) Percent slope analysis of dynamic magnetic resonance imaging for assessment of chemotherapy response of osteosarcoma or Ewing sarcoma: systematic review and meta-analysis. Skeletal Radiol 45:1235\u20131242. https:\/\/doi.org\/10.1007\/s00256-016-2410-y","journal-title":"Skeletal Radiol"},{"key":"732_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00264-014-2606-5","volume":"39","author":"CJ Laux","year":"2015","unstructured":"Laux CJ, Berzaczy G, Weber M et al (2015) Tumour response of osteosarcoma to neoadjuvant chemotherapy evaluated by magnetic resonance imaging as prognostic factor for outcome. Int Orthop 39:97\u2013104. https:\/\/doi.org\/10.1007\/s00264-014-2606-5","journal-title":"Int Orthop"},{"key":"732_CR7","doi-asserted-by":"publisher","unstructured":"Biermann JS, Hirbe A, Ahlawat S et al (2025) Bone cancer, version 2.2025, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. https:\/\/doi.org\/10.6004\/jnccn.2025.0017","DOI":"10.6004\/jnccn.2025.0017"},{"key":"732_CR8","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1148\/rg.210171","volume":"42","author":"JC Nguyen","year":"2022","unstructured":"Nguyen JC, Baghdadi S, Pogoriler J, Guariento A, Rajapakse CS, Arkader A (2022) Pediatric osteosarcoma: correlation of imaging findings with histopathologic features, treatment, and outcome. Radiographics 42:1196\u20131213. https:\/\/doi.org\/10.1148\/rg.210171","journal-title":"Radiographics"},{"key":"732_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1588302","volume":"12","author":"T Kanthawang","year":"2025","unstructured":"Kanthawang T, Pattamapaspong N, Settakorn J et al (2025) Development and validation of a predictive score for chemoresistance in high-grade osteosarcoma at baseline. Front Med 12:1588302. https:\/\/doi.org\/10.3389\/fmed.2025.1588302","journal-title":"Front Med"},{"key":"732_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00256-022-04098-2","volume":"52","author":"LM White","year":"2023","unstructured":"White LM, Atinga A, Naraghi AM et al (2023) T2-weighted MRI radiomics in high-grade intramedullary osteosarcoma: predictive accuracy in assessing histologic response to chemotherapy, overall survival, and disease-free survival. Skeletal Radiol 52:553\u2013564. https:\/\/doi.org\/10.1007\/s00256-022-04098-2","journal-title":"Skeletal Radiol"},{"key":"732_CR11","doi-asserted-by":"publisher","unstructured":"Prudowsky ZD, Yustein JT (2020) Recent insights into therapy resistance in osteosarcoma. Cancers. https:\/\/doi.org\/10.3390\/cancers13010083","DOI":"10.3390\/cancers13010083"},{"key":"732_CR12","doi-asserted-by":"publisher","first-page":"7913","DOI":"10.1007\/s00330-021-07748-6","volume":"31","author":"H Chen","year":"2021","unstructured":"Chen H, Zhang X, Wang X et al (2021) MRI-based radiomics signature for pretreatment prediction of pathological response to neoadjuvant chemotherapy in osteosarcoma: a multicenter study. Eur Radiol 31:7913\u20137924. https:\/\/doi.org\/10.1007\/s00330-021-07748-6","journal-title":"Eur Radiol"},{"key":"732_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.758921","volume":"11","author":"L Zhang","year":"2021","unstructured":"Zhang L, Ge Y, Gao Q et al (2021) Machine learning-based radiomics nomogram with dynamic contrast-enhanced MRI of the osteosarcoma for evaluation of efficacy of neoadjuvant chemotherapy. Front Oncol 11:758921. https:\/\/doi.org\/10.3389\/fonc.2021.758921","journal-title":"Front Oncol"},{"key":"732_CR14","doi-asserted-by":"publisher","first-page":"6196","DOI":"10.1007\/s00330-022-08735-1","volume":"32","author":"J Zhong","year":"2022","unstructured":"Zhong J, Zhang C, Hu Y et al (2022) Automated prediction of the neoadjuvant chemotherapy response in osteosarcoma with deep learning and an MRI-based radiomics nomogram. Eur Radiol 32:6196\u20136206. https:\/\/doi.org\/10.1007\/s00330-022-08735-1","journal-title":"Eur Radiol"},{"key":"732_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13244-022-01277-6","volume":"13","author":"J Zhong","year":"2022","unstructured":"Zhong J, Hu Y, Zhang G et al (2022) An updated systematic review of radiomics in osteosarcoma: utilizing CLAIM to adapt the increasing trend of deep learning application in radiomics. Insights Imaging 13:138. https:\/\/doi.org\/10.1186\/s13244-022-01277-6","journal-title":"Insights Imaging"},{"key":"732_CR16","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/s0009-9260(05)83135-6","volume":"50","author":"HC Holscher","year":"1995","unstructured":"Holscher HC, Bloem JL, van der Woude HJ et al (1995) Can MRI predict the histopathological response in patients with osteosarcoma after the first cycle of chemotherapy? Clin Radiol 50:384\u2013390. https:\/\/doi.org\/10.1016\/s0009-9260(05)83135-6","journal-title":"Clin Radiol"},{"key":"732_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-020-1576-0","volume":"15","author":"B Zhang","year":"2020","unstructured":"Zhang B, Zhang Y, Li R, Li J, Lu X, Zhang Y (2020) The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis. J Orthop Surg Res 15:51. https:\/\/doi.org\/10.1186\/s13018-020-1576-0","journal-title":"J Orthop Surg Res"},{"key":"732_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13244-023-01415-8","volume":"14","author":"B Kocak","year":"2023","unstructured":"Kocak B, Baessler B, Bakas S et al (2023) CheckList for EvaluAtion of Radiomics research (CLEAR): a step-by-step reporting guideline for authors and reviewers endorsed by ESR and EuSoMII. Insights Imaging 14:75. https:\/\/doi.org\/10.1186\/s13244-023-01415-8","journal-title":"Insights Imaging"},{"key":"732_CR19","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1007\/s11999-010-1315-7","volume":"468","author":"MU Jawad","year":"2010","unstructured":"Jawad MU, Scully SP (2010) In brief: Classifications in brief: Enneking classification: benign and malignant tumors of the musculoskeletal system. Clin Orthop Relat Res 468:2000\u20132002. https:\/\/doi.org\/10.1007\/s11999-010-1315-7","journal-title":"Clin Orthop Relat Res"},{"key":"732_CR20","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1148\/radiol.12111740","volume":"265","author":"LM Fayad","year":"2012","unstructured":"Fayad LM, Jacobs MA, Wang X, Carrino JA, Bluemke DA (2012) Musculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniques. Radiology 265:340\u2013356. https:\/\/doi.org\/10.1148\/radiol.12111740","journal-title":"Radiology"},{"key":"732_CR21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00256-018-3079-1","volume":"48","author":"A Saifuddin","year":"2019","unstructured":"Saifuddin A, Sharif B, Gerrand C, Whelan J (2019) The current status of MRI in the pre-operative assessment of intramedullary conventional appendicular osteosarcoma. Skeletal Radiol 48:503\u2013516. https:\/\/doi.org\/10.1007\/s00256-018-3079-1","journal-title":"Skeletal Radiol"},{"key":"732_CR22","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.2106\/00004623-198062060-00028","volume":"62","author":"WF Enneking","year":"1980","unstructured":"Enneking WF, Spanier SS, Goodman MA (1980) Current concepts review. The surgical staging of musculoskeletal sarcoma. J Bone Jt Surg Am 62:1027\u20131030","journal-title":"J Bone Jt Surg Am"},{"key":"732_CR23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/bjr\/tqad047","volume":"97","author":"T Kanthawang","year":"2024","unstructured":"Kanthawang T, Wudhikulprapan W, Phinyo P et al (2024) Can conventional magnetic resonance imaging at presentation predict chemoresistance in osteosarcoma? Br J Radiol 97:451\u2013461. https:\/\/doi.org\/10.1093\/bjr\/tqad047","journal-title":"Br J Radiol"},{"key":"732_CR24","unstructured":"Fujifilm SYNAPSE 3D. Available via https:\/\/synapse-emea.fujifilm.com\/synapse-3d.html. (Accessed 23 Mar 2026)"},{"key":"732_CR25","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/1097-0142(19851001)56:7<1515::AID-CNCR2820560707>3.0.CO;2-6","volume":"56","author":"P Picci","year":"1985","unstructured":"Picci P, Bacci G, Campanacci M et al (1985) Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy. Regional mapping of viable and nonviable tumor. Cancer 56:1515\u20131521. https:\/\/doi.org\/10.1002\/1097-0142(19851001)56:7<1515::aid-cncr2820560707>3.0.co;2-6","journal-title":"Cancer"},{"key":"732_CR26","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1109\/TSMC.1973.4309314","volume":"3","author":"RM Haralick","year":"1973","unstructured":"Haralick RM, Shanmugam K, Dinstein I (1973) Textural features for image classification. IEEE Trans Syst Man Cybern 3:610\u2013621. https:\/\/doi.org\/10.1109\/TSMC.1973.4309314","journal-title":"IEEE Trans Syst Man Cybern"},{"key":"732_CR27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0734-189X(83)90032-4","volume":"23","author":"C Sun","year":"1983","unstructured":"Sun C, Wee WG (1983) Neighboring gray level dependence matrix for texture classification. Comput Vis Graph Image Process 23:341\u2013352. https:\/\/doi.org\/10.1016\/0734-189X(83)90032-4","journal-title":"Comput Vis Graph Image Process"},{"key":"732_CR28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0146-664X(75)80008-6","volume":"4","author":"MM Galloway","year":"1975","unstructured":"Galloway MM (1975) Texture analysis using gray level run lengths. Comput Graph Image Process 4:172\u2013179. https:\/\/doi.org\/10.1016\/S0146-664X(75)80008-6","journal-title":"Comput Graph Image Process"},{"key":"732_CR29","unstructured":"Thibault G, Fertil B, Navarro CL et al (2009) Texture indexes and gray level size zone matrix: application to cell nuclei classification. In: 10th International Conference on Pattern Recognition and Information Processing. PRIP 2009, Minsk, Belarus, pp. 140\u2013145. https:\/\/hal.science\/hal-01499715"},{"key":"732_CR30","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1109\/21.44046","volume":"19","author":"M Amadasun","year":"1989","unstructured":"Amadasun M, King R (1989) Textural features corresponding to textural properties. IEEE Trans Syst Man Cybern 19:1264\u20131274. https:\/\/doi.org\/10.1109\/21.44046","journal-title":"IEEE Trans Syst Man Cybern"},{"key":"732_CR31","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM Van Griethuysen","year":"2017","unstructured":"Van Griethuysen JJM, Fedorov A, Parmar C et al (2017) Computational radiomics system to decode the radiographic phenotype. Cancer Res 77:e104\u2013e107. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0339","journal-title":"Cancer Res"},{"key":"732_CR32","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14:749\u2013762. https:\/\/doi.org\/10.1038\/nrclinonc.2017.141","journal-title":"Nat Rev Clin Oncol"},{"key":"732_CR33","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1093\/bioinformatics\/btq134","volume":"26","author":"A Altmann","year":"2010","unstructured":"Altmann A, Tolo\u015fi L, Sander O, Lengauer T (2010) Permutation importance: a corrected feature importance measure. Bioinformatics 26:1340\u20131347. https:\/\/doi.org\/10.1093\/bioinformatics\/btq134","journal-title":"Bioinformatics"},{"key":"732_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3515080","volume":"2019","author":"SY Jeong","year":"2019","unstructured":"Jeong SY, Kim W, Byun BH et al (2019) Prediction of chemotherapy response of osteosarcoma using baseline 18F-FDG textural features machine learning approaches with PCA. Contrast Media Mol Imaging 2019:3515080. https:\/\/doi.org\/10.1155\/2019\/3515080","journal-title":"Contrast Media Mol Imaging"},{"key":"732_CR35","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.210107","volume":"4","author":"A Bouhamama","year":"2022","unstructured":"Bouhamama A, Leporq B, Khaled W et al (2022) Prediction of histologic neoadjuvant chemotherapy response in osteosarcoma using pretherapeutic MRI radiomics. Radiol Imaging Cancer 4:e210107. https:\/\/doi.org\/10.1148\/rycan.210107","journal-title":"Radiol Imaging Cancer"},{"key":"732_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s41747-024-00467-9","volume":"8","author":"R Roudi","year":"2024","unstructured":"Roudi R, Pisani LJ, Pisani F, Liang T, Daldrup-Link HE (2024) Reproducibility and repeatability of quantitative T2 and T2* mapping of osteosarcomas in a mouse model. Eur Radiol Exp 8:74. https:\/\/doi.org\/10.1186\/s41747-024-00467-9","journal-title":"Eur Radiol Exp"},{"key":"732_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.semradonc.2005.12.006","volume":"16","author":"HR Withers","year":"2006","unstructured":"Withers HR, Lee SP (2006) Modeling growth kinetics and statistical distribution of oligometastases. Semin Radiat Oncol 16:111\u2013119. https:\/\/doi.org\/10.1016\/j.semradonc.2005.12.006","journal-title":"Semin Radiat Oncol"},{"key":"732_CR38","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.2174\/1381612023394025","volume":"8","author":"S Pervaiz","year":"2002","unstructured":"Pervaiz S (2002) Anti-cancer drugs of today and tomorrow: are we close to making the turn from treating to curing cancer? Curr Pharm Des 8:1723\u20131734. https:\/\/doi.org\/10.2174\/1381612023394025","journal-title":"Curr Pharm Des"},{"key":"732_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13244-022-01177-9","volume":"13","author":"EJ Inarejos Clemente","year":"2022","unstructured":"Inarejos Clemente EJ, Navarro OM, Navallas M et al (2022) Multiparametric MRI evaluation of bone sarcomas in children. Insights Imaging 13:33. https:\/\/doi.org\/10.1186\/s13244-022-01177-9","journal-title":"Insights Imaging"},{"key":"732_CR40","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/01.rli.0000225398.17315.68","volume":"41","author":"M Uhl","year":"2006","unstructured":"Uhl M, Saueressig U, van Buiren M et al (2006) Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging. Invest Radiol 41:618\u2013623. https:\/\/doi.org\/10.1097\/01.rli.0000225398.17315.68","journal-title":"Invest Radiol"},{"key":"732_CR41","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1148\/radiology.162.1.3786772","volume":"162","author":"J Beltran","year":"1987","unstructured":"Beltran J, Simon DC, Katz W, Weis LD (1987) Increased MR signal intensity in skeletal muscle adjacent to malignant tumors: pathologic correlation and clinical relevance. Radiology 162:251\u2013255. https:\/\/doi.org\/10.1148\/radiology.162.1.3786772","journal-title":"Radiology"},{"key":"732_CR42","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1148\/radiology.182.3.1535905","volume":"182","author":"HC Holscher","year":"1992","unstructured":"Holscher HC, Bloem JL, Vanel D et al (1992) Osteosarcoma: chemotherapy-induced changes at MR imaging. Radiology 182:839\u2013844. https:\/\/doi.org\/10.1148\/radiology.182.3.1535905","journal-title":"Radiology"},{"key":"732_CR43","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s00256-012-1383-8","volume":"41","author":"KZ Masrouha","year":"2012","unstructured":"Masrouha KZ, Musallam KM, Samra AB et al (2012) Correlation of non-mass-like abnormal MR signal intensity with pathological findings surrounding pediatric osteosarcoma and Ewing\u2019s sarcoma. Skeletal Radiol 41:1453\u20131461. https:\/\/doi.org\/10.1007\/s00256-012-1383-8","journal-title":"Skeletal Radiol"},{"key":"732_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2020.100281","volume":"21","author":"S Xin","year":"2020","unstructured":"Xin S, Wei G (2020) Prognostic factors in osteosarcoma: a study level meta-analysis and systematic review of current practice. J Bone Oncol 21:100281. https:\/\/doi.org\/10.1016\/j.jbo.2020.100281","journal-title":"J Bone Oncol"},{"key":"732_CR45","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13244-023-01572-w","volume":"15","author":"B Kocak","year":"2024","unstructured":"Kocak B, Akinci D\u2019Antonoli T, Mercaldo N et al (2024) METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII. Insights Imaging 15:8. https:\/\/doi.org\/10.1186\/s13244-023-01572-w","journal-title":"Insights Imaging"},{"key":"732_CR46","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00247-010-1876-3","volume":"41","author":"J Bajpai","year":"2011","unstructured":"Bajpai J, Gamnagatti S, Kumar R et al (2011) Role of MRI in osteosarcoma for evaluation and prediction of chemotherapy response: correlation with histological necrosis. Pediatr Radiol 41:441\u2013450. https:\/\/doi.org\/10.1007\/s00247-010-1876-3","journal-title":"Pediatr Radiol"},{"key":"732_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2019.100263","volume":"19","author":"S Zhao","year":"2019","unstructured":"Zhao S, Su Y, Duan J et al (2019) Radiomics signature extracted from diffusion-weighted magnetic resonance imaging predicts outcomes in osteosarcoma. J Bone Oncol 19:100263. https:\/\/doi.org\/10.1016\/j.jbo.2019.100263","journal-title":"J Bone Oncol"},{"key":"732_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-019-0283-8","volume":"20","author":"P Lin","year":"2020","unstructured":"Lin P, Yang PF, Chen S et al (2020) A Delta-radiomics model for preoperative evaluation of neoadjuvant chemotherapy response in high-grade osteosarcoma. Cancer Imaging 20:7. https:\/\/doi.org\/10.1186\/s40644-019-0283-8","journal-title":"Cancer Imaging"},{"key":"732_CR49","unstructured":"Jolliffe IT (2002) Principal component analysis, 2nd edn. Springer, New York"},{"key":"732_CR50","doi-asserted-by":"publisher","unstructured":"Lorensen WE, Cline HE (1987) Marching cubes: a high resolution 3D surface construction algorithm. In: Proceedings of the 14th annual conference on computer graphics and interactive techniques. Association for Computing Machinery, pp 163\u2013169. https:\/\/doi.org\/10.1145\/37401.37422","DOI":"10.1145\/37401.37422"},{"key":"732_CR51","doi-asserted-by":"publisher","unstructured":"Dhawan AP (2008) Wavelet transform and its applications in medical image analysis. Principles and advanced methods in medical imaging and image analysis. World Scientific, pp 437\u2013454. https:\/\/doi.org\/10.1142\/9789812814807_0018","DOI":"10.1142\/9789812814807_0018"}],"container-title":["European Radiology Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-026-00732-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41747-026-00732-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-026-00732-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:53:36Z","timestamp":1779288816000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41747-026-00732-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["732"],"URL":"https:\/\/doi.org\/10.1186\/s41747-026-00732-z","relation":{},"ISSN":["2509-9280"],"issn-type":[{"value":"2509-9280","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Chiang Mai University (approval no. RAD-2566-0535) and the Institutional Review Board of Prince of Songkla University (approval no. 68-111-7-1). A data-sharing agreement was established between both institutions. The requirement for written informed consent was waived because this study involved retrospective data collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of de-identified clinical information and imaging data was obtained from all patients in the internal dataset cohort. For the external dataset, all data and images were fully anonymized, and no directly or indirectly identifiable information is presented. Therefore, consent for publication is not applicable for the external dataset.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}